Prosecution Insights
Last updated: April 19, 2026
Application No. 18/664,684

METHOD OF INTRODUCING A BARE FIBER TIP INTO A HANDPIECE, SCOPE, OR CANNULA WITHOUT DAMAGE

Non-Final OA §102§103§112
Filed
May 15, 2024
Examiner
BAYS, PAMELA M
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Optical Integrity Inc.
OA Round
1 (Non-Final)
72%
Grant Probability
Favorable
1-2
OA Rounds
4y 3m
To Grant
99%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allow Rate
403 granted / 560 resolved
+2.0% vs TC avg
Strong +37% interview lift
Without
With
+37.2%
Interview Lift
resolved cases with interview
Typical timeline
4y 3m
Avg Prosecution
37 currently pending
Career history
597
Total Applications
across all art units

Statute-Specific Performance

§101
4.1%
-35.9% vs TC avg
§103
41.6%
+1.6% vs TC avg
§102
18.5%
-21.5% vs TC avg
§112
23.4%
-16.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 560 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims Claims 1-6 are presently pending in this application. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-6 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding Claim 1, the claim recites “the therapeutic or surgical fiber”. There is lack of antecedent basis for this limitation in the claims. It appears this limitation is referring to the previously recited “optical fiber”, and therefore will be interpreted as such by the Examiner. Appropriate correction or clarification is required. Claims 2-6 are rejected for depending on Claim 1. Regarding Claim 1, the claim recites “the handpiece”. There is lack of antecedent basis for this limitation in the claims. For purposes of examination, the Examiner will interpret this limitation as “a handpiece”. Appropriate correction or clarification is required. Claims 2-6 are rejected for depending on Claim 1. Regarding Claim 5, the claim recites “the temporary protective sleeve has a color that is different than a color of the buffer of the optical fiber”. However, “the buffer” lacks antecedent basis in the claims, because Claim 4 (from which Claim 5 depends) only recites “a section of a buffer of the optical fiber that has been stripped from the optical fiber”. Therefore, it is unclear as to whether “the temporary protective sleeve” is referring to the same or a different ‘buffer’ than the section of buffer that has been removed. Therefore, this limitation is indefinite. For purposes of examination, the Examiner will interpret this limitation as “the temporary protective sleeve has a color that is different than a color of a buffer on the optical fiber which has not been removed”. Appropriate correction or clarification is required. Claims 2-6 are rejected for depending on Claim 1. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 2, 4, and 6 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Bierbaum et al. (US Publication No. 2010/0216088). Regarding Claims 1 and 6, Bierbaum et al. discloses a method of preparing for a therapeutic or surgical procedure (Abstract; Paragraph 0002, 0007), comprising steps of: providing an optical fiber (fiber-optic insert 10, Figs. 1, 2, 5, 8; Abstract, Paragraph 0051, 0055, 0056) having a pre-formed tip (see tip of fiber-optic insert 10, Figs. 1, 2, 5, 8); placing a temporary protective sleeve (sleeve 80, Fig. 8; and base member 21, Fig. 2) over the pre-formed tip (Paragraph 0020, 0076-0077, 0055-0057, 0059, 0080, 0036, 0064; Abstract); inserting the optical fiber (fiber-optic insert 10, Figs. 1, 2, 5, 8) with the protective sleeve through the handpiece (grip/handpiece, 3, 4, 5, Figs. 1, 2, 4; Paragraph 0020, 0076-0077, 0055-0057, 0059, 0080, 0036, 0064; Abstract); and before beginning the therapeutic or surgical procedure, removing the protective sleeve from the optical fiber (Paragraph 0020, 0076-0077, 0055-0057, 0059, 0080, 0036, 0064; Abstract), wherein the temporary protective sleeve is reusable (reusable elements, Paragraph 0008, 0020, 0076-0077, 0055-0057, 0059, 0080, 0036, 0064). Regarding Claim 2, Bierbaum et al. discloses the method further wherein the temporary protective sleeve (sleeve 80, Fig. 8; and base member 21, Fig. 2) is configured to grip the therapeutic or surgical fiber during insertion through the handpiece (Paragraph 0020, 0076-0077, 0055-0057, 0059, 0080, 0036, 0064; Abstract), while enabling removal of the temporary protective sleeve from the optical fiber by a technician after completion of insertion through the handpiece (Paragraph 0020, 0076-0077, 0055-0057, 0059, 0080, 0036, 0064; Abstract). Regarding Claim 4, Bierbaum et al. discloses the method further wherein the temporary protective sleeve (sleeve 80, Fig. 8; and base member 21, Fig. 2) is a section of a buffer of the optical fiber that has been stripped from the optical fiber (section of material that is removable from optical fiber, see Paragraphs 0076-0077, 0055-0057, 0059, 0080, 0036, 0064; e.g. see tube 8 and/or hose 2, Fig. 1). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim 3 is rejected under 35 U.S.C. 103 as being unpatentable over Bierbaum et al. (US Publication No. 2010/0216088). Regarding Claim 3, Bierbaum et al. discloses the method further wherein the temporary protective sleeve (sleeve 80, Fig. 8; and base member 21, Fig. 2) is placed over the optical fiber, (fiber-optic insert 10, Figs. 1, 2, 5, 8; Abstract, Paragraph 0051, 0055, 0056), but does not explicitly disclose wherein the temporary protective sleeve is made of PTFE or ETFE. However, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to configure the temporary protective sleeve to be made of PTFE or ETFE, since these are known biocompatible materials used in medical devices, and since it has been held to be within the general skill of a worker in the art to select a known material on the basis of its suitability for the intended use as a matter of obvious design choice. In re Leshin, 125 USPQ 416. Sinclair & Carroll Co. v. Interchemical Corp., 325 U.S. 327, 65 USPQ 297 (1945). Claim 5 is rejected under 35 U.S.C. 103 as being unpatentable over Bierbaum et al. (US Publication No. 2010/0216088) in view of Leeflang et al. (US Publication No. 20100087789). Regarding Claim 5, Bierbaum et al. discloses the method further wherein the temporary protective sleeve (sleeve 80, Fig. 8; and base member 21, Fig. 2) is a section of a buffer of the optical fiber that has been stripped from the optical fiber (section of material that is removable from optical fiber, see Paragraphs 0076-0077, 0055-0057, 0059, 0080, 0036, 0064; e.g. see tube 8 and/or hose 2, Fig. 1). However, Bierbaum et al. does not explicitly disclose wherein the temporary protective sleeve has a color that is different than a color of the buffer of the optical fiber. Leeflang et al. teaches a method including a medical device for a therapeutic or surgical procedure (Abstract) wherein different tubular sections of the medical device are different colors, in order to facilitate identification of the different/distinct sections (Paragraph 0010, 0011, 0101, 0151). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to configure the temporary protective sleeve to have a color that is different than a color of the buffer of the optical fiber, in the method disclosed by Bierbaum et al., in order to facilitate identification of the different/distinct sections, as taught by Leeflang et al., since such a modification would have involved a mere change in the form of a component. A change in form is generally recognized as being within the level of ordinary skill in the art. In re Dailey, 149 USPQ 47 (CCPA 1976). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to PAMELA M BAYS whose telephone number is (571)270-7852. The examiner can normally be reached 9:00am - 6:00pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached at 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PAMELA M. BAYS/Primary Examiner, Art Unit 3796
Read full office action

Prosecution Timeline

May 15, 2024
Application Filed
Feb 21, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12599339
SYSTEMS AND METHODS FOR AFFECTING CARDIAC CONTRACTILITY AND/OR RELAXATION
2y 5m to grant Granted Apr 14, 2026
Patent 12589236
An Implantable Artificial Heart
2y 5m to grant Granted Mar 31, 2026
Patent 12569692
WIRELESS NEUROSTIMULATORS
2y 5m to grant Granted Mar 10, 2026
Patent 12564355
Micro Motion Detection for Determining at least one Vital Sign of a Subject
2y 5m to grant Granted Mar 03, 2026
Patent 12558539
DETECTING AND TREATING DISORDERED BREATHING
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
72%
Grant Probability
99%
With Interview (+37.2%)
4y 3m
Median Time to Grant
Low
PTA Risk
Based on 560 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month